Clinical trial

Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine

NCT00126217 · Bandim Health Project, Other · Terminated

Key facts

NCT number NCT00126217
Title Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine
Official title BCG Vaccination and Childhood Morbidity and Mortality: Interventions With Possible Implications for the Immunisation Policy in Developing Countries. Revaccination of Young Children With BCG Vaccine.
Lead sponsor Bandim Health Project, Other
Collaborators International Cooperation with Developing Countries Leiden University Medical Centre, DEPT of Parasitology, Leiden Holland Medical Research Council Unit, The Gambia
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Malaria
Intervention type Biological
Interventions Bacille Calmette Guerin (BCG)
Enrollment 2,871
Start date Jul 1, 2002
Primary completion May 1, 2006
Completion Sep 1, 2006
First posted Aug 3, 2005
Last update posted Oct 21, 2008
Countries Guinea-Bissau

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies